CRP was found specifically to be positively correlated with two parts of a Continuous Performance Test (CPT) conducted in patients who had resolved COVID-19 infections (Zhou et al., 2020a) and was found at significantly elevated concentration in COVID-19 patients with moderate to severe cognitive dysfunction (Arica-Polat et al., 2022). The gene discussed is CRP; the disease is COVID-19.